Sciclone Pharmaceuticals Stock Total Asset
SciClone Pharmaceuticals fundamentals help investors to digest information that contributes to SciClone Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of SciClone Stock. The fundamental analysis module provides a way to measure SciClone Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SciClone Pharmaceuticals stock.
SciClone |
SciClone Pharmaceuticals Company Total Asset Analysis
SciClone Pharmaceuticals' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current SciClone Pharmaceuticals Total Asset | 216.62 M |
Most of SciClone Pharmaceuticals' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SciClone Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, SciClone Pharmaceuticals has a Total Asset of 216.62 M. This is 97.12% lower than that of the sector and 99.66% lower than that of the Total Asset industry. The total asset for all United States stocks is 99.26% higher than that of the company.
SciClone Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SciClone Pharmaceuticals' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SciClone Pharmaceuticals could also be used in its relative valuation, which is a method of valuing SciClone Pharmaceuticals by comparing valuation metrics of similar companies.SciClone Pharmaceuticals is currently under evaluation in total asset category among related companies.
SciClone Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 25.82 % | |||
| Current Valuation | 422 M | |||
| Shares Outstanding | 52.19 M | |||
| Shares Owned By Insiders | 10.03 % | |||
| Shares Owned By Institutions | 79.96 % | |||
| Number Of Shares Shorted | 1.21 M | |||
| Price To Earning | 13.75 X | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 3.38 X | |||
| Revenue | 172.02 M | |||
| Gross Profit | 137.2 M | |||
| EBITDA | 45.42 M | |||
| Net Income | 43.31 M | |||
| Cash And Equivalents | 157.33 M | |||
| Cash Per Share | 3.01 X | |||
| Total Debt | 2.73 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 8.36 X | |||
| Book Value Per Share | 3.53 X | |||
| Cash Flow From Operations | 35.74 M | |||
| Short Ratio | 2.34 X | |||
| Earnings Per Share | 0.81 X | |||
| Price To Earnings To Growth | 0.84 X | |||
| Number Of Employees | 590 | |||
| Beta | 1.25 | |||
| Market Capitalization | 581.94 M | |||
| Total Asset | 216.62 M | |||
| Retained Earnings | (115.06 M) | |||
| Working Capital | 131.7 M | |||
| Current Asset | 168.52 M | |||
| Current Liabilities | 36.82 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in SciClone Stock
If you are still planning to invest in SciClone Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SciClone Pharmaceuticals' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |